NO953792L - Plaster med virksomme stoffer for avgivelse av östradiol til huden - Google Patents

Plaster med virksomme stoffer for avgivelse av östradiol til huden

Info

Publication number
NO953792L
NO953792L NO953792A NO953792A NO953792L NO 953792 L NO953792 L NO 953792L NO 953792 A NO953792 A NO 953792A NO 953792 A NO953792 A NO 953792A NO 953792 L NO953792 L NO 953792L
Authority
NO
Norway
Prior art keywords
pct
active substance
skin
ch2oh
sec
Prior art date
Application number
NO953792A
Other languages
English (en)
Other versions
NO953792D0 (no
Inventor
Teresa Maria Murphy
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of NO953792D0 publication Critical patent/NO953792D0/no
Publication of NO953792L publication Critical patent/NO953792L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

Et plaster med virksomt stoff for avgivelse av østradiol på hu- den, er karakterisert ved at det består av et bakre lag og et dermed forbundet reservoar for virksomt stoff, som innbefatter et kontakt- klebemiddel i hvilket det virksomme stoff i det minste delvis er løse- lig, samt av et f jernbart beskyt- telseslag som dekker klebefilmen, idet reservoaret for det virksomme stoff er en polymermatriks som er tilsatt en gjennomtrengings-aksele- rator for forbedring av bioforen- ligheten av østradiolet, og med den generelle formel
NO953792A 1993-03-26 1995-09-25 Plaster med virksomme stoffer for avgivelse av östradiol til huden NO953792L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4309830A DE4309830C1 (de) 1993-03-26 1993-03-26 Wirkstoffpflaster für die Abgabe von Estradiol an die Haut
PCT/EP1994/000670 WO1994022481A1 (de) 1993-03-26 1994-03-07 Wirkstoffpflaster für die abgabe von estradiol an die haut

Publications (2)

Publication Number Publication Date
NO953792D0 NO953792D0 (no) 1995-09-25
NO953792L true NO953792L (no) 1995-09-25

Family

ID=6483909

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953792A NO953792L (no) 1993-03-26 1995-09-25 Plaster med virksomme stoffer for avgivelse av östradiol til huden

Country Status (23)

Country Link
US (1) US5686098A (no)
EP (1) EP0689458B1 (no)
JP (1) JPH08508266A (no)
KR (1) KR960700754A (no)
AT (1) ATE173636T1 (no)
AU (1) AU681383B2 (no)
CA (1) CA2156746A1 (no)
CZ (1) CZ287544B6 (no)
DE (2) DE4309830C1 (no)
DK (1) DK0689458T3 (no)
ES (1) ES2127384T3 (no)
FI (1) FI954497A (no)
GR (1) GR3029387T3 (no)
HR (1) HRP940213A2 (no)
HU (1) HU220861B1 (no)
IL (1) IL109084A (no)
NO (1) NO953792L (no)
NZ (1) NZ262418A (no)
PL (1) PL173547B1 (no)
SK (1) SK280246B6 (no)
WO (1) WO1994022481A1 (no)
YU (1) YU14394A (no)
ZA (1) ZA941987B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4429664C2 (de) * 1994-08-20 1997-09-11 Lohmann Therapie Syst Lts Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
DE4429663C2 (de) * 1994-08-20 1997-09-11 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Hydrolyseschutz
DE19526864A1 (de) * 1995-07-22 1997-01-23 Labtec Gmbh Hormonpflaster
FR2749586B1 (fr) * 1996-06-11 1998-08-07 Hoechst Marion Roussel Inc Nouveaux dispositifs destines a l'administration transdermique de la trimegestone, leur procede de preparation et leur application a titre de medicaments
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
DE19702314C2 (de) * 1997-01-23 2000-12-21 Lohmann Therapie Syst Lts Ablösbare Schutzfolie für wirkstoffhaltige, insbesondere selbstklebende Pflastersysteme
FR2776191B1 (fr) * 1998-03-23 2002-05-31 Theramex Composition hormonale topique a effet systemique
DE19828273B4 (de) * 1998-06-25 2005-02-24 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
FR2789586A1 (fr) * 1999-02-16 2000-08-18 Synthelabo Composition pharmaceutique pour administration transmucosale balanique d'alfuzosine
DE10008128A1 (de) * 2000-02-22 2001-08-23 Bayer Ag Endoparasitizide Mittel
DE10033853A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
FR2869232B1 (fr) * 2004-04-21 2007-09-21 Gattefosse Sas Soc Par Actions Nouveaux excipients pharmaceutiques ou cosmetiques a base d'acetals cyliques
DE102004062182B4 (de) * 2004-12-20 2007-06-06 Bayer Schering Pharma Ag Transdermales Pflaster mit Progesteron A-Spezifische Liganden (PRASL) als Wirkstoff
US20060134188A1 (en) * 2004-12-20 2006-06-22 Hans-Peter Podhaisky Transdermal pharmaceutical preparation with a progesterone A-specific ligand (PRASL) as active ingredient
FR2912149B1 (fr) * 2007-02-05 2012-10-12 Rhodia Poliamida E Especialidades Ltda Utilisation de derives de dioxolane dans des systemes de revetement et formulation de systeme de revetement
CA2696632C (en) * 2007-08-17 2014-05-27 Arcion Therapeutics, Inc. High concentration local anesthetic formulations
DE102008059054A1 (de) * 2008-11-26 2010-05-27 Otto Bock Pur Life Science Gmbh Polyurethanpflaster für die transdermale Applikation von Wirkstoffen und Verfahren zu dessen Herstellung
JP5639208B2 (ja) * 2013-02-22 2014-12-10 ロディア・ポリアミダ・エ・エスペシアリダデス・リミターダＲｈｏｄｉａ Ｐｏｌｉａｍｉｄａ Ｅ Ｅｓｐｅｃｉａｌｉｄａｄｅｓ Ｌｔｄａ コーティング系におけるジオキソラン誘導体の使用及びコーティング系配合物
JP5576523B2 (ja) * 2013-02-22 2014-08-20 ロディア・ポリアミダ・エ・エスペシアリダデス・リミターダ コーティング系におけるジオキソラン誘導体の使用及びコーティング系配合物
CN116157211B (zh) * 2020-08-26 2024-03-08 中国涂料株式会社 低voc涂料组合物、涂膜和具有涂膜的基材以及它们的制造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1385914A (en) * 1971-10-19 1975-03-05 Wigglesworth Ltd Compositions having bactericidal activity
BE795226A (fr) * 1972-02-11 1973-08-09 Syntex Corp Vehicule pour pommade contenant du dimethyl-2,2dioxolane-1,3 methanol-4
US4818540A (en) * 1985-02-25 1989-04-04 Rutgers, The State University Of New Jersey Transdermal fertility control system and process
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
US4906169A (en) * 1986-12-29 1990-03-06 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
US4746515A (en) * 1987-02-26 1988-05-24 Alza Corporation Skin permeation enhancer compositions using glycerol monolaurate
ATE101511T1 (de) * 1988-08-02 1994-03-15 Ciba Geigy Ag Mehrschichtiges pflaster.
WO1991005529A1 (en) * 1989-10-13 1991-05-02 Watson Laboratories, Inc. Drug delivery systems and matrix therefor
SE8904296D0 (sv) * 1989-12-21 1989-12-21 Pharmacia Ab Transdermal system

Also Published As

Publication number Publication date
JPH08508266A (ja) 1996-09-03
HRP940213A2 (en) 1998-02-28
EP0689458A1 (de) 1996-01-03
SK280246B6 (sk) 1999-10-08
HUT73425A (en) 1996-07-29
NO953792D0 (no) 1995-09-25
ATE173636T1 (de) 1998-12-15
WO1994022481A1 (de) 1994-10-13
GR3029387T3 (en) 1999-05-28
FI954497A0 (fi) 1995-09-22
ZA941987B (en) 1995-04-05
CA2156746A1 (en) 1994-10-13
PL310555A1 (en) 1995-12-27
IL109084A (en) 1996-12-05
CZ248995A3 (en) 1996-03-13
IL109084A0 (en) 1994-06-24
YU14394A (sh) 1997-01-08
HU9502794D0 (en) 1995-11-28
AU6208394A (en) 1994-10-24
PL173547B1 (pl) 1998-03-31
DE59407345D1 (de) 1999-01-07
AU681383B2 (en) 1997-08-28
HU220861B1 (en) 2002-06-29
SK120695A3 (en) 1997-02-05
ES2127384T3 (es) 1999-04-16
DK0689458T3 (da) 1999-08-09
EP0689458B1 (de) 1998-11-25
US5686098A (en) 1997-11-11
CZ287544B6 (en) 2000-12-13
FI954497A (fi) 1995-09-22
KR960700754A (ko) 1996-02-24
NZ262418A (en) 1996-08-27
DE4309830C1 (de) 1994-05-05

Similar Documents

Publication Publication Date Title
NO953792L (no) Plaster med virksomme stoffer for avgivelse av östradiol til huden
PT739199E (pt) Adesivo de estradiol com agente reforcador da penetracao
AU679032B2 (en) Transdermal therapeutic system with galanthamine as active ingredient
NZ333866A (en) Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents
NO972565L (no) Estradiolholdig plaster
NO951523L (no) Plaster for transdermal administrering av flyktige, farmasöytisk aktive, kjemisk basiske bestanddeler, samt fremgangsmåte for fremstilling av plasteret
AU2003215657A1 (en) Hormone-containing transdermal therapeutic system with an active substance reservoir based on vinylacetate-vinylpyrrolidone copolymer with improved cohesion.
FI953532A0 (fi) Nitroglyserolia sisältävä laastari, menetelmä sen valmistamiseksi ja sen käyttö
ES2105334T3 (es) Sistema terapeutico percutaneo para la administracion de fisostigmina en la piel y el procedimiento para su obtencion.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application